|
|
.
See Category: Diseases of the genitourinary system
See Header: Fibrosclerosis of breast
ICD-10 (CM) Code and Descriptor
|
N60.32 |
Fibrosclerosis of left breast
|
N6032 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 34.46%
|
30.35%
|
17.92%
|
8.77%
|
4.26%
|
1.75%
|
0.93%
|
0.56%
|
0.30%
|
0.14%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for N60.32*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
2,387
|
2,802
|
|
77065
|
DX MAMMO INCL CAD UNI |
1,413
|
1,416
|
|
A4648
|
IMPLANTABLE TISSUE MARKER |
1,321
|
1,490
|
|
19083
|
BX BREAST 1ST LESION US IMAG |
1,293
|
1,294
|
|
19081
|
BX BREAST 1ST LESION STRTCTC |
786
|
786
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
418
|
480
|
|
G0279
|
TOMOSYNTHESIS, MAMMO |
343
|
344
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
290
|
587
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
258
|
7,774
|
|
J3010
|
FENTANYL CITRATE INJECTION |
255
|
347
|
|
J2405
|
ONDANSETRON HCL INJECTION |
252
|
1,081
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
218
|
256
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
215
|
899
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
199
|
762
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
187
|
1,209
|
|
76098
|
X-RAY EXAM SURGICAL SPECIMEN |
178
|
188
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
161
|
338
|
|
J2001
|
LIDOCAINE INJECTION |
158
|
1,656
|
|
76642
|
ULTRASOUND BREAST LIMITED |
136
|
139
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
133
|
260
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
N60.32 related to the following DRG Codes:
600-601
|
